Search results
Results from the WOW.Com Content Network
Launched in July 2001 under the name EcstasyData, its purpose was to collect ecstasy pill samples sent anonymously by the public, in order to manage, review, and publicly report laboratory test results from a variety of organizations [28] As the site evolved into DrugsData, the service expanded to testing samples of most recreational drugs, and ...
MDMA INN: Midomafetamine [1]; Clinical data; Pronunciation: methylenedioxymethamphetamine: / ˌ m ɛ θ ɪ l iː n d aɪ ˈ ɒ k s i / / ˌ m ɛ θ æ m ˈ f ɛ t əm iː n / Other names: 3,4-MDMA; Ecstasy (E, X, XTC); Midomafetamine; Molly; Mandy; [2] [3] Pingers/Pingas [4]
MDMA/citalopram is a combination of the entactogen and monoamine releasing agent 3,4-methylenedioxymethamphetamine (MDMA; also known as midomafetamine or "ecstasy") and the selective serotonin reuptake inhibitor (SSRI) citalopram which is under development for the treatment of post-traumatic stress disorder (PTSD).
Matthew John Baggott is an American neuroscientist who studies entactogens, hallucinogens, and other psychoactive drugs. [5] [6] [1] [7] [8] He is considered to be an expert on MDMA and other entactogens and is an influential figure in the psychedelic medicine movement.
3,4-Methylenedioxyamphetamine (MDA) is an empathogen-entactogen, stimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. [3]
Lykos Therapeutics, formerly known as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) that is developing MDMA ("ecstasy") as a potential medicine. [1]
Bag and contents of a well-known early brand of synthetic cannabinoids named Spice that contains herbs covered with synthetic cannabinoids, now illegal throughout much of the world
meta-Chlorophenylpiperazine (mCPP) is a psychoactive drug of the phenylpiperazine class. It was initially developed in the late-1970s and used in scientific research before being sold as a designer drug in the mid-2000s.